Inhibition of GLI Transcriptional Activity and Prostate Cancer Cell Growth and Proliferation by DAX1

• Published in: Current Issues in Molecular Biology Vol. 45; no. 7; pp. 5347 - 5361
• Main Authors: Hong, Sung Pyo, Kim, Kil Won, Ahn, Soon Kil
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 27.06.2023; MDPI
• Subjects: Cancer; DAX1; DNA binding proteins; Genetic aspects; Genetic research; Genetic transcription; GLI transcription factor; hedgehog signaling; Medical research; Medicine, Experimental; Prostate cancer; South Korea; Massachusetts; DAX1; prostate cancer; GLI transcription factor; hedgehog signaling
• ISSN: 1467-3045; 1467-3037; 1467-3045
• DOI: 10.3390/cimb45070339

The Hedgehog (Hh) signaling pathway plays an essential role in the initiation and progression of prostate cancer. This is mediated by transcriptional factors belonging to the GLI (glioma-associated oncogene) family, which regulate downstream targets to drive prostate cancer progression. The activity of GLI proteins is tightly controlled by a range of mechanisms, including molecular interactions and post-translational modifications. In particular, mitogenic and oncogenic signaling pathways have been shown to regulate GLI protein activity independently of upstream Hh pathway signaling. Identifying GLI protein regulators is critical for the development of targeted therapies that can improve patient outcomes. This study aimed to identify a novel protein that directly regulates the activity of GLI transcription factors in prostate cancer. We performed gene expression, cellular analyses, and reporter assays to demonstrate that DAX1 (dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on X chromosome, gene 1) interacts with GLI1 and GLI2, the master regulators of Hh signaling. Interestingly, DAX1 overexpression significantly inhibited Hh signaling by reducing GLI1 and GLI2 activity, prostate cancer cell proliferation, and viability. Our results shed light on a novel regulatory mechanism of Hh signaling in prostate cancer cells. The interaction between DAX1 and GLI transcription factors provides insight into the complex regulation of Hh signaling in prostate cancer. Given the importance of Hh signaling in prostate cancer progression, targeting DAX1-GLI interactions may represent a promising therapeutic approach against prostate cancer. Overall, this study provides new insights into the regulation of the Hh pathway and its role in prostate cancer progression. The findings suggest that DAX1 could serve as a potential therapeutic target for the treatment of prostate cancer.